1![Award ID: DP150096 Project Title: ESR1 Coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy resistant metastatic breast cancer Award Mechanism: Award ID: DP150096 Project Title: ESR1 Coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy resistant metastatic breast cancer Award Mechanism:](https://www.pdfsearch.io/img/5e51e609537ebad11a65ee07bb1dc35e.jpg) | Add to Reading ListSource URL: www.cprit.state.tx.usLanguage: English - Date: 2014-11-20 01:49:24
|
---|
2![References for Substances Tested in the In Vitro ER Binding Assays: Appx D2 - ICCVAM ER Binding BRD (NIH Publication No[removed]) References for Substances Tested in the In Vitro ER Binding Assays: Appx D2 - ICCVAM ER Binding BRD (NIH Publication No[removed])](https://www.pdfsearch.io/img/9e5e3c7fc0c2e4e5bf17cb36604ab23a.jpg) | Add to Reading ListSource URL: ntp.niehs.nih.govLanguage: English - Date: 2015-02-24 12:59:01
|
---|
3![ACOG COMMITTEE OPINION Number 412 • August 2008 Aromatase Inhibitors in Gynecologic Practice Committee on ACOG COMMITTEE OPINION Number 412 • August 2008 Aromatase Inhibitors in Gynecologic Practice Committee on](https://www.pdfsearch.io/img/40a3db14ba3c324a0c6f87db3f2660c9.jpg) | Add to Reading ListSource URL: www.acog.orgLanguage: English - Date: 2014-12-22 17:24:49
|
---|
4![Shift work and adverse health effects: possible biological mechanisms Shift work and adverse health effects: possible biological mechanisms](https://www.pdfsearch.io/img/5d75973db1317535e5d20adbf55cabb8.jpg) | Add to Reading ListSource URL: www.iwh.on.caLanguage: English - Date: 2014-12-03 00:38:52
|
---|
5![Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix J Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix J](https://www.pdfsearch.io/img/3307818c54688efa8c0c9c5236eb60c8.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2007-11-01 13:27:51
|
---|
6![Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix J Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix J](https://www.pdfsearch.io/img/71df24c35da40e12e0197a78ef532719.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2007-11-01 13:27:51
|
---|
7![Copy of proposed-ehb-benchmark-plan-michigan1.xlsx Copy of proposed-ehb-benchmark-plan-michigan1.xlsx](https://www.pdfsearch.io/img/245a648303f56abb3a61d3f543673074.jpg) | Add to Reading ListSource URL: michigan.govLanguage: English - Date: 2012-12-17 13:41:33
|
---|
8![Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class](https://www.pdfsearch.io/img/f5665aa052d35fd78e058d595b4253cc.jpg) | Add to Reading ListSource URL: dvha.vermont.govLanguage: English - Date: 2013-05-21 21:10:49
|
---|
9![Abstracts of Papers Presented at the 1993 Technical Meeting Abstracts of Papers Presented at the 1993 Technical Meeting](https://www.pdfsearch.io/img/cabe59cadafa5fccee9686f46469d741.jpg) | Add to Reading ListSource URL: digital.library.okstate.eduLanguage: English - Date: 2009-01-09 17:06:48
|
---|
10![Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class](https://www.pdfsearch.io/img/793027efba1f6be0961c9bdcae3a11ed.jpg) | Add to Reading ListSource URL: dvha.vermont.govLanguage: English - Date: 2013-05-21 21:10:49
|
---|